We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRN
3551
Amarin Corp
AMRN
$299M
$16.6K ﹤0.01%
696
+91
+15% +$2.34K
FPH icon
3552
Five Point Holdings
FPH
$372M
$16.6K ﹤0.01%
5,734
+1,128
+24% +$2.71K
KALV
3553
DELISTED
KalVista Pharmaceuticals
KALV
$16.6K ﹤0.01%
1,840
+806
+78% +$7.43K
SCHD icon
3554
Schwab US Dividend Equity ETF
SCHD
$108B
$16.6K ﹤0.01%
684
-15,216
-96% -$364K
TXO icon
3555
TXO Partners LP
TXO
$783M
$16.5K ﹤0.01%
+764
New +$17K
MBB icon
3556
iShares MBS ETF
MBB
$39.2B
$16.5K ﹤0.01%
177
-1,403
-89% -$132K
LBTYB
3557
DELISTED
Liberty Global plc Class B
LBTYB
$16.5K ﹤0.01%
980
+17
+2% +$286
EQBK icon
3558
Equity Bancshares
EQBK
$1.07B
$16.5K ﹤0.01%
723
+143
+25% +$3.35K
FXNC icon
3559
First National Corp
FXNC
$291M
$16.5K ﹤0.01%
996
+447
+81% +$6.86K
TARS icon
3560
Tarsus Pharmaceuticals
TARS
$3.02B
$16.5K ﹤0.01%
911
+42
+5% +$668
FGNX
3561
FG Nexus Inc
FGNX
$43.5M
$16.4K ﹤0.01%
25
-3
-11% -$809
LOMA
3562
Loma Negra
LOMA
$1.11B
$16.4K ﹤0.01%
2,410
+2,165
+884% +$14.1K
TRNS icon
3563
Transcat
TRNS
$888M
$16.4K ﹤0.01%
192
-74
-28% -$6.3K
TPIC
3564
DELISTED
TPI Composites
TPIC
$16.4K ﹤0.01%
1,578
+626
+66% +$7.01K
ABUS icon
3565
Arbutus Biopharma
ABUS
$906M
$16.4K ﹤0.01%
7,112
-2,680
-27% -$6.98K
MHUA
3566
DELISTED
Meihua International Medical Technologies
MHUA
$16.3K ﹤0.01%
57
+9
+19% +$3.18K
APYX icon
3567
Apyx Medical
APYX
$128M
$16.3K ﹤0.01%
+3,247
New +$16.5K
ORGO icon
3568
Organogenesis Holdings
ORGO
$226M
$16.3K ﹤0.01%
4,918
+868
+21% +$2.56K
OUST icon
3569
Ouster
OUST
$3.25B
$16.3K ﹤0.01%
3,305
+165
+5% +$862
ORIC icon
3570
Oric Pharmaceuticals
ORIC
$1.42B
$16.3K ﹤0.01%
+2,103
New +$11.9K
SNDL icon
3571
Sundial Growers
SNDL
$311M
$16.3K ﹤0.01%
11,910
+6,924
+139% +$10.5K
DIVI icon
3572
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.78B
$16.3K ﹤0.01%
+558
New +$16.3K
CCSI icon
3573
Consensus Cloud Solutions
CCSI
$717M
$16.3K ﹤0.01%
525
+35
+7% +$1.23K
GWH icon
3574
ESS Tech
GWH
$19.6M
$16.2K ﹤0.01%
736
+288
+64% +$5.2K
BWFG icon
3575
Bankwell Financial Group
BWFG
$542M
$16.2K ﹤0.01%
663
+255
+63% +$6.05K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.